Holen Sie sich die Stockscreener-App
24.09
0.08%
-0.02
Handel nachbörslich:
24.09
Artivion Inc Aktie (AORT) Neueste Nachrichten
What Boosted Artivion (NYSE:AORT) Following FDA PMA Approval? - Kalkine Media
Artivion (AORT) Is Up 10.1% After Full FDA PMA Approval for AMDS Aortic Device - simplywall.st
Artivion seeks to tap $150 million US market opportunity with FDA approval - MSN
Artivion stock gets FDA approval for NEXUS stent graft system By Investing.com - Investing.com India
Artivion (AORT) Stock Forum and Discussion - Moomoo
AORTArtivion Inc Options - Finviz
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion Secures FDA Approval for AMDS Hybrid Prosthesis Device - Yahoo Finance
Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion (NYSE:AORT) - Seeking Alpha
Artivion stock rises after FDA approves AMDS device - Investing.com
Enterprise value to revenue forward of Artivion, Inc. – SWB:CYL - TradingView
Canaccord reiterates Artivion stock rating on FDA approval By Investing.com - Investing.com South Africa
Artivion (AORT) Secures FDA Approval for AMDS Hybrid Prosthesis - GuruFocus
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval - Benzinga
Why Artivion (AORT) Is Up 17.3% After Full FDA PMA Approval for AMDS Hybrid Prosthesis - simplywall.st
Artivion receives FDA PMA approval for AMDS Hybrid Prosthesis in aortic dissections - grafa.com
Canaccord reiterates Artivion stock rating on FDA approval - Investing.com
Artivion Shares Rise After FDA Approves AMDS Aortic Device - TradingPedia
Artivion Wins FDA Nod for AMDS Hybrid Prosthesis - Medical Product Outsourcing
Artivion stock rises after FDA approves AMDS device By Investing.com - Investing.com Canada
Artivion, Inc.(NYSE: AORT) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Artivion's Hybrid Prosthesis Device Gets FDA Premarket Approval; Shares Up Pre-Bell - Moomoo
Artivion receives FDA approval for aortic dissection device By Investing.com - Investing.com South Africa
Artivion receives FDA approval for aortic dissection device - Investing.com
Artivion, Inc.(NYSE: AORT) dropped from Russell 2000 Value Benchmark - marketscreener.com
Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis - PR Newswire
Artivion, Inc.(NYSE: AORT) dropped from Russell 3000E Index - marketscreener.com
Artivion, Inc.(NYSE: AORT) dropped from Russell Microcap Index - marketscreener.com
Artivion, Inc.(NYSE: AORT) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Artivion, Inc.(NYSE: AORT) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Price to earnings forward of Artivion, Inc. – NYSE:AORT - TradingView
Enterprise value to EBITDA forward of Artivion, Inc. – SWB:CYL - TradingView
Price to sales forward of Artivion, Inc. – SWB:CYL - TradingView
Artivion, Inc.(NYSE: AORT) dropped from Russell 3000E Value Benchmark - marketscreener.com
Artivion, Inc. Actuals & Estimates (NYSE:AORT) - TradingView
AORT Forecast — Price Target — Prediction for 2027 - TradingView
AORT Q1 2026 Earnings: EPS Misses Estimates, Yet Stock Gains 2.86% on Operational ResilienceEarnings Analysis - dars.gov.et
Artivion Inc (AORT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Needham Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $44 - Moomoo
At US$21.19, Is It Time To Put Artivion, Inc. (NYSE:AORT) On Your Watch List? - Moomoo
Q1 2026 Artivion Inc Earnings Call Transcript - GuruFocus
Delray Medical Center is First Hospital in Palm Beach County to Perform Procedure Using AMDS™ Hybrid Prothesis Developed by Artivion Inc. - Florida Hospital News and Healthcare Report
Artivion Inc (AORT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Artivion Inc (AORT) Institutional Confidence - TradingKey
Artivion Inc (AORT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Artivion Inc (AORT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AORT Q1 2026 Earnings: EPS Misses Estimates by 40%, Shares DeclineRevenue Report - dars.gov.et
Artivion Inc (AORT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Artivion Inc (AORT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Artivion Inc (AORT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AORT Q1 2026 Earnings: EPS Misses Estimates, Stock Dips on Mixed Operating PerformanceEarnings Power Value - dars.gov.et
Artivion Inc. (AORT) Gains 2.28% as Stock Approaches Key ResistanceDip Buy Trade - newsline.com
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):